<DOC>
	<DOCNO>NCT02974686</DOCNO>
	<brief_summary>Patients receive renal transplantation BJH place triple maintenance immunosuppression , mean patient take 3 type immunosuppression drug suppress immune system include tacrolimus , mycophenolate ( MPA ) , prednisone . However , due effect MPA gastrointestinal tract , patient often complain GI adverse effect . Current practice either dose-reduce MPA convert patient alternative agent , typically Azathioprine . Both strategy limitation , largely due concern related efficacy . Everolimus ( EVR ) demonstrate similar efficacy MPA renal transplantation may offer benefit related GI adverse effect , investigator convert patient EVR study . Patients within first year post-transplant convert EVR upon enrollment study , serial measurement , series measurement look increase decrease time , GI adverse effect conduct 1 year post-enrollment .</brief_summary>
	<brief_title>Conversion From MPA Zortress ( Everolimus ) GI Toxicity Post-renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>1 . Kidney transplant recipient Washington University/BarnesJewish Hospital 2 . Experiencing GI toxicity MPA determine treat physician within 12 month postrenal transplant 3 . On standard immunosuppression tacrolimus prednisone 1 . Dual organ kidney another solid organ transplant 2 . Presence preexist significant GI condition presume causal relationship MPA 3 . Evidence GI disorder induce infection , underlie medical condition , concomitant medication MPA 4. eGFR &lt; 40 ml/min time possible conversion 5 . Proteinuria &gt; 1 gram/day time possible conversion 6 . Profound bone marrow suppression time possible conversion define : Hemoglobin &lt; 10 g/dL WBC &lt; 3 K/cumm Platelets &lt; 100 K/cumm 7 . Wound heal issue time possible conversion ( eg , wound dehiscence , wound infection , incisional hernia , lymphocele , seroma ) 8 . Elevated total cholesterol ( &gt; 350 mg/dL ) and/or triglyceride ( &gt; 500 ng/dL ) time possible conversion 9 . Hypersensitivity everolimus , sirolimus , rapamycin deriviatives</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>